LIXTE Biotechnology Announces ~$16.57M Registered Direct Offering, Selling ~2.625M Shares And Pre-Funded Warrants At A Combined Price Of $6.31

Loading news article.

LIXTE Biotechnology Announces ~$16.57M Registered Direct Offering, Selling ~2.625M Shares And Pre-Funded Warrants At A Combined Price Of $6.31 | WAPE

Article summary